johnson and johnson

National News

US health panel urges restarting J&J COVID-19 vaccinations

By Lauran Neergaard and Mike Stobbe
Associated Press,

A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots. Out of nearly 8 million people vaccinated before the U.S. suspended J&J’s shot, health officials uncovered 15 cases of a highly unusual kind of blood clot, three of them fatal.
National News

US health panel reviews J&J vaccine pause over rare clots

By Lauran Neergaard and Mike Stobbe
Associated Press,

U.S. authorities are weighing whether to resume the Johnson & Johnson vaccine more than a week after a pause was issued out of an abundance of caution. A government advisory panel is discussing a possible link between J&J’s shot and a handful of vaccine recipients who developed highly unusual blood clots. New guidance is expected later in the day.

J And J Vax Kids
National News

Johnson & Johnson testing its vaccine in teens

CNN,

Good news for your kids who want to get vaccinated as well, Johnson & Johnson says it is testing its single-dose COVID-19 vaccine in teens. The company will start by adding 16 and 17-year-olds to its phase 2a trials, which have been ongoing since September.

Kids Vaccines
National News

Clinical vaccine trials for younger children begin

CNN,

Right now, the three COVID-19 vaccines on the U.S. market are for adults. You must be 18 or older to get Moderna and Johnson & Johnson vaccines, and 16 or older for the vaccine made by Pfizer. Clinical trials are now underway for younger children.